Adler L. A., Angrist B., Reiter S, and Rotrosen J. (1989) Neuroleptic-induced akathisia: A review. Psychopharmacology
97, 1–11.
|
| |
| Alpert M., Diamond F., and Friedhoff A. J. (1976) at]Tremographic studies in tardive dyskinesia. Psychopharmacol. Bull.
12(2), 5.
|
| |
Ayd F. J. (1961) A survey of drug-induced extrapyramidal reactions. JAMA
175, 1054–1060.
|
| |
Barnes T. R. and Braude W. M. (1985) Akathesia variants and tardive dyskinesia. Arch. Gen. Psychiat.
42, 874–878.
|
| |
Bedard P., Delean J., Lafleur J., and LarocheIIe L.(1977) Haloperidol-induced dyskinesias in the monkey. J. Can. Sci.
4, 197–201.
|
| |
Beresford R. and Ward A. (1987) Haloperidol decanoate: A preliminary review of its pharmacodynamic and pharmacokinetic properties
and therapeutic use in psychosis. Drugs
33, 31–49.
|
| |
Burke R. E., Fahn S, Jankovic J., Marsden C. D., Lang A. E., Gollomp S., and IIson J. (1982) Tardive dystonia: Late-onset
and persistent dystonia caused by antipsychotic drugs. Neurology
32, 1335–1346.
|
| |
CaIigiuri M., Jeste D., and Harris M. (1989) Instrumental assessment of lingual motor instability in tardive dyskinesia. Neuropsychopharmacology
2, 309–312.
|
| |
Casey D. E. (1984) Tardive dyskinesia-animal models. Psychopharmacol. Bull.
20, 376–379.
|
| |
| Casey D. E. (1985a) Tardive dyskinesia: Epidemiologic factors as a guide for prevention and management, in Chronic Treatments in Neuropsychiatry (Kemali D. and Racagni G., eds.), Raven, NY, pp. 15–24.
|
| |
| Casey D. E. (1985b) Tardive dyskinesia: Reversible and irreversible, in Dyskinesia—Research and Treatment (Casey D. E., Chase T. N., Christensen A. V, and Gerlach J., eds.), Springer, Heidelberg, pp. 88–97.
|
| |
| Chien C., Jung K., and Ross-Townsend A. (1980) Methodological approach to the measurement of tardive dyskinesia: Piezoelectric
recording and concurrent validity test on give give clinical rating scales. Tardive Dyskinesia: Research and Treatmentl (Prann W., Smith R, Davis J., and Domino E., eds.). Spectrum Publications, New York, NY, pp. 233–241.
|
| |
Clow A., Jenner I’., and Marsden C. D. (1979) Changes in dopamine-medi-ated behaviour during one year’s neuroleptic administration.
Eur. J; Pharmacol.
57, 365–375.
|
| |
Clow A., Theodorou A., Jenner P., and Marsden C. D. (1980) Cerebral do-pamine function in rats following withdrawal from one
year of continuous neuroleptic administration. Eur. J. Pharmucol.
63, 145–157.
|
| |
Crane G. E. (1973) Persistent dyskinesia. Br. J. Psychiat
122, 395–405.
|
| |
| Creese I.(1983) Receptor interactions of neuroleptics, in Neuroleptics: Neurochemical., Behavioral, and Clinical Perspectives (Coyle J. T. and Enna S. J., eds.), Raven, NY, pp. 183–223.
|
| |
Csernansky J. G., Grabowski K, Cervantes J., Kaplan J., and Yesavage J. A. (1981) Fluphenazine decanoate and tardive dyskinesia:
A possible association. Am. J. Psychiat.
138(10), 1362–1365.
|
| |
| Deneau G. and Crane G. (1969) Dyskinesia in rhesus monkeys tested with high doses of chlorpromazine, in Psychotropic Drugs and Dysfunction of the Basal Ganglia (Crane G. and Gardner R., eds.), US Public Health Service, Washington, DC, pp. 12–14.
|
| |
Domino E. and Kovacic B. (1983) Monkey models of tardive dyskinesia. Mod. Probl. PharmacoPsychiat.
21, 21–33.
|
| |
| Domino E. F. (1985) Induction of tardive dyskinesia in Cebus apella and macaca speciosa monkeys: A review, in Dyskinesia—Research and Treatment (Casey D. E, Chase T. N., Christensen A. V., and Gerlach J., eds.), Springer, Heidelberg, pp. 217–223.
|
| |
Ellison G. and Morris W. (1981) Opposed stages of continuous amphetamine administration: Parallel alterations in motor stereotypies
and in vivo spiroperidol accumulation. Eur. J. Pharmacol.
74, 207–214.
|
| |
Ellison G. D. and See R. E. (1989) Rats administered chronic neuroleptics develop oral movements which are similar in form
to those in humans with tardive dyskinesia. Psychopharmacology
98, 564–566.
|
| |
Ellison G., Staugaitis S., and Crane P. (1981) A silicone delivery system for producing binge and continuous ethanol intoxication
in rats. Pharmacol. Biochem. Behav.
14, 207–211.
|
| |
Ellison G., Eison M., Huberman H., and Daniel P. (1978) Structural and biochemical alterations in dopaminergic innervation
of the caudate nucleus following continuous amphetamine administration. Science
201, 276–278.
|
| |
Ellison G. D., See R. E., Levin E. D, and Kinney J. (1987) Tremorous mouth movements in rats administered chronic neuroleptics.
Psychoyharmacology
92, 122–126.
|
| |
Fann W. E., Stafford J., Malone R., Frost J., and Richman B. (1977) Clinical research techniques in tardive dyskinesia. Am. J. Psychiat.
134, 759.
|
| |
Gardos G., Cole J. 0, and Tarsy D. (1978) Withdrawal syndromes associated with antipsycholic drugs. Am.1. Psychiat
135, 1321–1324.
|
| |
Gardos G., Cole J. O., Salomon M, and Schnielbolk S. (1987) Clinical forms of severe tardive dyskinesia. Am. J. Psychiat.
144, 895–902.
|
| |
Gerlach J. and Casey D. E. (1984) Sulpiride in tardive dyskinesia. Acta Psychiatr. Stand. (Suppl.)
311, 93–102.
|
| |
Gerlach J., Koppelhus P., Helweg E, and Monrad A. V. (1974) Clozapine and haloperidol in single-blind cross-over trial: Therapeutic
and biochemical aspects in the treatment of schizophrenia. Acta Psychiatr. Stand.
50, 410–424.
|
| |
Glassman R. and Glassman H. (1980) Oral dyskinesias in brain-damaged rats withdrawn from a neuroleptic: Implications for models
of tardive dyskinesia. Psychopharmacology
69, 19–25.
|
| |
Goldman M. B. and Luchins D. J. (1984) Intermittent neuroleptic therapy and tardive dyskinegia: A literature review. Hosp. Comm. Psychiat.
35, 1215–1219.
|
| |
Gunne L. M. and Barany S. (1976) Haloperidol-induced tardive dyskinesia in monkeys. Psychopharmacology
50, 237–240.
|
| |
Gunne L. M. and Haggstrom J. E. (1983) Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral
dyskinesia. Psychopharmacology
81, 191–194.
|
| |
Gunne L. M., Haggstrom J.E., and Syoquist B. (1984) Association with persistent neuroleptic-induced dyskinesia of regional
changes in brain GABA synthesis. Nature
309(24), 347–349.
|
| |
Gunne L. M., Andersson U, Bondesson U., and Johansson P. (1986) Spontaneous chewing movements in rats during acute and chronic
anti-psychotic drug administration. Pharmacol. Biochem. Behav.
25, 897–901.
|
| |
Guy W., Ban T. A., and Wilson W. H. (1985) An international survey of tardive dyskinesia. Prog. Neuropsychopharmacol. Biol. Psychiat.
9, 401–405.
|
| |
Hall H., Kohler C., Gawell L., Farde L., and Sedvall G. (1988) Raclopride, a new selective ligand for the dopamine-D2 receptors.
Prog. Neuroysycoyharmacol. Biol. Psychiat, 12, 559–568.
|
| |
Iversen S. D., Howells R. B., and Hughes R. P. (1980) Behavioral consequences of long-term treatment with neuroleptic drugs.
Adv. Biochem. Psychoyharmacol.
24, 305–313.
|
| |
Jeste D. V., Lohr J. B., Clark K, and Wyatt R. J. W. (1988) Pharmacological treatments of tardive dyskinesia in the 1980s.
J Clin. Psychopharmacol.
8, 385–485.
|
| |
Jeste D. V. and Wyatt R. J. W. (1982) Therapeutic strategies against tardive dyskinesia: Two decades of experience. Arch. Gen. Psychiat.
39, 803–816.
|
| |
| Johansson P. (1989) Characterization and application of animal models for tardive dyskinesia. Uppsala, Sweden, Acta Univ. Uysaliensis
222, pp. 1–46.
|
| |
Johansson P., Casey D. E., and Gunne L. M. (1986) Dose-dependent increases in rat spontaneaus chewing rates during long-term
administration of haloperidol but not clozapine. Psychopharmacol. Bull.
22, 1017–1019.
|
| |
Kane J. M. and Smith J. M. (1982) Tardive dyskinesia: Prevalence and risk factors, 1959-1979. Arch. Gen. Psychiat.
39, 473–481.
|
| |
Klawans H. L. (1973) The pharmacology of tardive dyskinesias. Am. J Psychiat.
130, 82–86.
|
| |
Kovacic B. and Domino E. F. (1984) Fluphenazine-induced acute and tardive dyskinesia in monkeys. Psychopharmacology
84, 310–314.
|
| |
Kovacic B., Ruffmg D., and Stanley M. (1986) Effect of neuroleptics and of potential new antipsychotic agents (MJ13859-1 and
MJ13980-1) on a monkey model of tardive dyskinesia. J. Neural. Transm.
165, 39–49.
|
| |
| Lees A. J. (1985) Tics and Related Disorders (Churchill Livingstone, Eding-burgh), pp. 191–234.
|
| |
Levin E. D., Galen D., and Ellison G. D. (1987) Chronic haloperidol effects on radial-arm maze performance and oral movements
in rats. Pharmacol. Biochem. Behav.
26, 145.
|
| |
Levy A. D., See R. E., Levin E. D., and Ellison G. D. (1987) Neuroleptic-induced oral movements in rats: Methodological issues.
Life Sci.
41, 1499–1506.
|
| |
Liebman J. and Neale R. (1980) Neuroleptic-induced acute dyskinesias in squirrel monkeys: Correlation with propensity to cause
extrapyramidal side effects. Psychopharmacology
68, 25–29.
|
| |
Lindstrom L. H. (1988) The effect of long-term treatment with clozapine in schizophrenia: A retrospective study in 96 patients
treated with clozapine for up to 13 years. Acta Psychiatr. Scand.
77, 524–529.
|
| |
McGeer P. L., Boulding J. E., Gibson W. C., and Foulkes R. G. (1961) Druginduced extrapyramidal reactions.J. Am. Med. Assoc.
177, 665–670.
|
| |
McKinney W. T., Moran E. C., Kraemer G. W, and Prange A. J. (1980) Longterm chlorpromazine in rhesus monkeys: Production of
dyskinesias and changes in social behavior. Psychopharmacology
72, 35–39.
|
| |
Marsden C. D. and Jenner P. (1980) The pathophysiology of extrapyramidal side effects of neuroleptic drugs. Psychol. Med.
10, 55–72.
|
| |
Mithani S., Atmadja S., Baimbridge K. G., and Fibiger H. C. (1987) Neuroleptic-induced oral dyskinesias, effects of progabide
and lack of corre-lation with regional changes in glutamic acid decarboxylase and cho-line acetyltransferase activities. Psychopharmacology
93, 94–100.
|
| |
Moore D. C. and Bowers M. B. (1980) Identification for a subgroup of tardive dyskinesia patients by pharmacologic probes.
Am. J. Psychiat.
137, 1202–1205.
|
| |
Neale R., Gerhardt S., and Liebman J. M. (1984) Effects of dopamine agonists, catecholamine depletors, and cholinergic and
GABAergic drugs on acute dyskinesias in squirrel monkeys. Psychopharmacology
82, 20–26.
|
| |
Niemegeers C. J. E. and Janssen P. A. J. (1979) A systematic review of the pharmacological activities of dopamine antagonists.
Life Sci.
24, 2201–2216.
|
| |
Owen F., Cross A. J., Waddington J. L., Poulter M., Gamble S. J., and Crow T. J. (1980) Dopamine-mediated behaviour and 3H-spiperone
binding to striatal membranes in rats after nine months haloperidol administration. Life Sci.
26(l), 55–59.
|
| |
Pi E. H. and Simpson G. M. (1983) Atypical neuroleptics: Clozapine and the benzamides in the prevention and treatment of tardive
dyskinesia. Mod. Probl. PharmacoPsychiat.
21, 80–86.
|
| |
Post R. M. (1980) Intermittent versus continuous stimulation: Effect of time interval on the development of sensitization
or tolerance. Life Sci.
26, 1275–1282.
|
| |
Potthoff A. U, Ellison G, and Nelson L. (1983) Ethanol intake increases during continuous administration of amphetamine and
nicotine, but not several other drugs. Pharmacol. Biochem. Behav.
18, 489–495.
|
| |
Robertson A. and MacDonald C. (1984) Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
Pharmacol. Biochem. Behav.
21, 97–101.
|
| |
Rodriguez L. A., Moss D. E., Reyes E., and Camarena M. L. (1986) Perioral behaviors induced by cholinesterase inhibitors:
A controversial animal model. Pharmacol. Biochem. Behav.
25, 1217–1221.
|
| |
| Rondot P. and Bathien N. (1986) Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia:
EMG and pharmacologic study. Adv. Neural.
45, 361.
|
| |
Rosengarten H., Schweitzer J. W, and Priedhoff A. J. (1983) Induction of oral dyskinesias in naive rats by Dl stimulation.
Life Sci.
33, 2479–2482.
|
| |
Rosengarten H., Schweitzer J. W, and Friedhoff A. J. (1986) Selective dopamine D2 receptor reduction enhances a Dl mediated
oral dyskinesia in rats. Life Sci.
39, 29–35.
|
| |
Rupniak N. M. J., Jenner P., and Marsden C. D. (1983) Cholinegic manipulation of perioral behaviour induced by chronic neuroleptic
administration to rats. Psychopharmacology
79, 226–230.
|
| |
Rupniak N. M. J., Jenner P., and Marsden C. D. (1985) Pharmacological characterisation of spontaneous or drug-associated purposeless
chewing movements in rats. Psychopharmacology
85, 71–79.
|
| |
Rupniak N. M. J., Jenner P., and Marsden C. D. (1986) Acute dystonia induced by neuroleptic drug. Psychophurmacology
88, 403–419.
|
| |
Rupniak N. M. J., Mann S., Hall M. D., Fleminger S., Kilpatrick G., Jenner P., and Marsden C. D. (1984) Differential effects
of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat. Psychopharmarcology
84, 503.
|
| |
Sahakian B. J., Robbins T. W, and Iversen S. D. (1976) Pluphenthixol-induced hyperactivity by chronic dosing in rats. Eur. J. Pharmacol.
37, 169–178.
|
| |
Sant W. W. and Ellison G. (1984) Drug holidays alter onset of oral movements in rats following chronic haloperidol. Bio. Psychiut.
19, 95–99.
|
| |
See R. E. and Ellison G. (1990a) Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias
in rats. Psychopharmacology
100, 404–412.
|
| |
See R. E. and Ellison G. (1990b) Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine
and raclopride, in an animal model of tardive dyskinesia. Eur. J. Pharmacol.
181, 175–186.
|
| |
See R. E., Levin E. D., and Ellison G. D. (1988) Characteristics of oral movements in rats during and after chronic haloperidol
and fluphenazine administration, Psychopharmacology
94, 421–427.
|
| |
See R., Sant W. W., and Ellison G. (1987) Recording oral activity in rats reveals a long-lasting subsensitivity to haloperidol
as a function of duration of previous haloperidol treatment. Pharmucol. Biochem. Behuu.
28, 175–178.
|
| |
| Stewart B. R., Rupniak N. M. J., Jenner P., and Marsden C. D. (1988) Animal models of neuroleptic-induced acute dystonia,
in Advances in Neurology, vol. 50: Dystoniu
2 (Fahn S., Marsden C. D., and Calne D. B., eds.), Raven, New York., pp. 343–359.
|
| |
| Tamminga C. A. and Gerlach J. (1987) New neuroleptics and experimental antipsychotics in schizophrenia, in Psychopharmacology—The Third Generation of Progress (Meltzer H. Y, ed.), Raven, NY, pp. 1129–1140.
|
| |
Tarsy D. and Baldessarini R. (1974) Behavioral supersensitivity to apomorphine following chronic treatment with drugs which
interfere with synaptic function of catecholamines. Neuropharmacology
13, 927–928.
|
| |
Tryon W. W. and Pologe B. (1987) Accelerometric assessment of tardive dyskinesia. Am. J. Psychiat.
144, 1584–1587.
|
| |
Waddington J. L, Cross A. J., Gamble S. J., and Bourne R. C. (1983) Spontaneous orofacial dysldnesia and dopaminergic function
in rats after six months of neuroleptic treatment. Science
220, 530–532.
|
| |
Waddington J. L., Youssef H. A., Molloy A. G., O’Boyle K. M., and Pugh M. T. (1985) Association of intellectual impairment,
negative symptoral movements, and aging with tardive dyskinesia: Clinical and animal studies. J. Clin. Psychiat.
46, 29–33.
|
| |
Weiss B. and Santelli S. (1978) Dyskinesias evoked in monkeys by weekly administration of haloperidol. Science
200, 799–801.
|
| |
Wirshing W. C., Cummings J. L., Lathers P., and Engel J. (1989) The machine measured characteristics of tardive dyskinesia.
Schizoyhr. Res.
2, 240.
|
| |